Swiss drugs maker Novartis says its Indian subsidiary will continue to file patents for new drugs in India despite the rejection of its plea for patent protection for its anti-cancer treatment Gilvec.
Novartis’ seven-year legal battle failed after India’s Supreme Court ruled it was it was an amended version of an existing compound.
“We will continue with our investments in India even though
cautiously, new products which we launched, we will ask for patents
for these products and we hope that the ecosystem for intellectual
property in the country improves. Clearly we are disappointed with
the decision,” said Novartis India Managing Director Ranjit Shahani.
Many drugs firms seek to extend their patents by making minor compound changes, a process known as “evergreening”. It prevents cheaper generic versions from being sold.
“It’s hugely significant because eight million people with HIV are on treatment from India, more than 80 percent of these people get these drugs from India. In the area of HIV, this decision is path-breaking. Number two is this – by protecting generic competition and abusive practices of pharma companies like Novartis, I think the Supreme Court has safeguarded the rights of patients across the developing world,” said Neena Manghaney of Doctors without Borders.
This patients-before-patents approach is getting support from health services facing cuts and rising drugs bills and consumers alike, but hitting the drugs developers’ profits, and analysts warn it may dissuade innovation in the long term.
- 1Migrants with tickets denied access to Budapest train station
- 2Satellite images show ISIL destruction in Palmyra
- 3‘No person is illegal’ – Vienna holds rally for refugees
- 4Ukraine: deputies explain for and against the decentralisation law
- 5Hungary’s hardline stance on refugees ‘benefits’ people smugglers
- 1euronews live TV - News | euronews : the latest international news as video on demand
- 2International breaking news | euronews online world breaking news in video
- 3Caught red-handed: the Russian Major fighting in Ukraine
- 4Video footage shows massive explosion in Tianjin, China
- 5Momentum for Mars: Astronauts say mission is inevitable
- 6Ukraine puts top Russian general Gerasimov on ‘most wanted’ list
- 7Latest News Bulletin
- 8Snowden, Assange and Manning statues unveiled in Berlin
- 9Who came out top in the US Republican television debate?
- 10Why World Elephant Day matters
- 11International news | euronews, latest international news
- 12UK: at least 7 dead after plane crashes into road in Brighton
- 13Virginia:TV journalist and cameraman shot dead live on air
- 14ISIL militant group claims to have killed Croatian hostage in Egypt
- 15Earth Overshoot Day…Pushing Mother Nature too far
- 16Windows 10, three weeks on: the good, the bad and the ugly
- 17Bringing the trolls out of the dark: Russian ‘troll’ awarded 1 rouble damages
- 18As ‘Daily Show’ Jon Stewart’s tenure ends, scholars say goodbye to their research topic
- 19European Union News | euronews: latest breaking news and headlines about European Union
- 20Scientists find sinkhole cave under Mexico’s Kukulkan Castle Pyramid
Wires > News
- 08:04 CET Fleeing Islamic State killings in Syria, a family reaches Bavaria
- 07:19 CET Pakistan says ‘almost all’ Uighur militants eliminated
- 07:00 CET Native protesters seize oil wells in Peru to urge government action
- 06:49 CET Malaysia police to question Mahathir on anti-PM comments at rally
- 05:59 CET North Korea tells South not to crow about deal that ended standoff
- 03:58 CET Brazil convicts Odebrecht Group for slavery-like practices in…
- 03:13 CET Obama pushes for more U.S. ice-breaking might in Arctic
- 03:02 CET Israel slams Palestinians’ push to fly their flag at U.N.